Further studies should also investigate the association between baseline inflammatory burden and blood pressure responses to methotrexate in patients with RA, other autoimmune disorders, and patients without autoimmune disorders and a wide range of CRP concentrations. Here, CRP is linked to rheumatoid arthritis.